Regulation of the collagen phenotype expression of gamma-irradiated vascular smooth muscle cells by heparan mimetics (RGTA)

Journal of Biomedical Materials Research - Part A

Volumn 70, Issue 4, 2004, Pages 594-602

  Alexakis, C ^a   Strup, C ^b   Mestries, P ^a   Mathe D ^b   Caruelle, J P ^a   Barritault, D ^a   Kern, P ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

Collagen; Fibrosis; Gamma radiation; Heparan sulfate mimetic; Restenosis

Indexed keywords

BIOPOLYMERS; CELLS; COLLAGEN; GAMMA RAYS; MUSCLE; TISSUE;

CELL SURVIVAL; RESTENOSIS;

BIOMEDICAL ENGINEERING;

AMIDE; ANTIMITOTIC AGENT; BENZYL DERIVATIVE; BENZYLAMIDE; BIOPOLYMER; CARBOXYLIC ACID; COBALT 60; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DEXTRAN; HEPARAN; HEPARAN MIMETIC POLYMER; PROLINE; RGTA POLYMER; SULFATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSIS; GAMMA IRRADIATION; IN VITRO STUDY; ISOTOPE LABELING; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; RESTENOSIS; SWINE; TISSUE REPAIR; VASCULAR SMOOTH MUSCLE;

EID: 4344685523     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30119     Document Type: Article

References (49)

1. El Nabout R, Martin M, Remy J, Kern P, Robert L, Lafuma C. Collagen synthesis and deposition in cultured fibroblasts from subcutaneous radiation-induced fibrosis. Modification as a function of cell aging. Matrix 1989;9:411-420.
2. Remy J, Wegrowsky J, Crechet F, Martin M, Daburon F. Long-term overproduction of collagen in radiation-induced fibrosis. Radiat Res 1991;125:14-19.
3. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken EO. Increased collagen III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992;102:1920-1929.
4. Ehrhart EJ, Segarini P, Tsang MLS, Carrol AG, Barcellos-Hoff MH. Latent TGF-β1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation. FASEB J 1997;11:991-1002.
5. Cottin Y, Kollum M, Chan RC, Kim HS, Bhargava B, Vodovotz Y, Waksman R. Differential remodeling after balloon overstretch injury and either beta- or gamma-intracoronary radiation of porcine coronary arteries. Cardiovasc Radiat Med 2001; 2:75-82.
6. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, Satler LF, Mehran R, Serruys PW, Lansky AJ, Fitzgerald P, Bhargava B, Kent KM, Pichard AD, Leon MB Intiacoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000;101:2165-2171.
7. Teirstein PS, Massullo V, Jani S, Tripuraneni P. Initial studies with gamma radiotherapy to inhibit coronary restenosis. Cardiovasc Radiat Med 1999;1:3-7.
8. Lafont A, Guzman LA, Whitlow PL, Goormastic M, Cornhill JF, Chisolm GM. Restenosis after experimental angioplasty. Intimal, medial and adventitial changes associated with constrictive remodeling. Circ Res 1995;76:996-1002.
9. Labinaz M, Pels K, Hoffert C, Aggarwal S, O'Brien ER. Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res 1999;41:255-266.
10. Imanaka-Yoshida K, Matsuura R, Isaka N, Nakano T, Sakakura T, Yoshida T. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty. Virchows Arch 2001;439:185-190.
11. Xiang D, Huang D, Gai L, Liu H. Relationship between expression of type III collagen and phenotype of vascular smooth muscle cells in neointimal of stented coronary artery. Chin Med J 2000;113:324-327.
12. Wight T. Arterial wall. In: Comper WD, editor. Extracellular matrix, vol 1: tissue function. Melbourne, Australia: Harwood Academic; 1996. p 175-202.
13. Mestries P, Borchiellini C, Barbaud C, Duchesnay A, Escartin Q, Barritault D, Caruelle JP, Kern P. Chemically modified dextrans modulate expression of collagen phenotype by cultured smooth muscle cells in relation to the degree of carboxymethyl, benzylamide and sulfation substitutions. J Biomat Med Res 1998;42: 286-294.
14. Mestries P, Alexakis C, Papy-Garcia D, Duchesnay A, Barritault D, Caruelle JP, Kern P. Specific RGTA increases collagen V expression by cultured aortic smooth muscle cells via activation and protection of transforming growth factor-β1. Matrix Biol 2001;20:171-181.
15. Silver FH, Horvath I, Foran DJ. Viscoelasticity of vessel wall: the role of collagen and elastic fibers. Crit Rev Biomed Eng 200;29: 279-301.
16. Alexakis C, Guettoufi A, Mestries P, Strup C, Mathé D, Barbaud C, Barritault D, Caruelle JP, Kern P. Heparan mimetic regulates collagen expression and TGF-β1 distribution in gamma- irradiated human intestinal smooth muscle cells FASEB J 2001;15:1546-1554.
17. Tardieu M, Gamby C, Avramoglou T, Jozefonvicz J, Barritault D. Derivatized dextrans mimic heparin as stabilizers, potentiators and protectors of acidic or basic FGF. J Cell Physiol 1992; 150:194-203.
18. Meddahi A, Lemdjabar H, Caruelle JP, Barritault D, Hornebeck W. Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation. Biochimie 1995;77:703-706.
19. Meddahi A, Benoit J, Ayoub N, Sezeur A, Barritault D. Heparin-like polymers derived from dextran enhance colonic anastomosis resistance to leakage. J Biomed Mater Res. 1996;31:293-297.
20. Lafont J, Baroukh B, Berdal A, Colombier ML, Barritault D, Caruelle JP, Saffar JL. RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats. Growth Factors 1998;16:23-38.
21. Meddahi A, Brée F, Papy-garcia D, Gautron J, Barritault D, Caruelle JP. Pharmacological studies of RGTA11, a heparan sulfate mimetic polymer, efficient on muscle regeneration. J Biomed Med Res 2002;62:525-531.
22. Benazzoug Y, Logeart D, Labat-Robert J, Robert L, Jozefonvicz J, Kern P. Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem Pharmacol 1995;49:847-853.
23. Logeart D, Letourneur D, Jozefonvicz J, Kern P. Collagen synthesis by vascular smooth muscle cells in the presence of antiproliferative polysaccharides. J Biomed Mater Res. 1996;30:501-508.
24. Ledoux D, Papy-Garcia D, Escartin Q, Sagot MA, Cao Y, Barritault D, Courtois J, Hornebeck W, Caruelle JP. Human plasmin enzymatic activity is inhibited by chemically modified dextrans. J Biol Chem 2000;275:29383-29390.
25. Chaubet F, Champion J, Maiga O, Mauray S, Jozefonvicz J. Synthesis and structure-anticoagulant property relationships of functionalized dextran. Carbohydr Polym 1995;28:145-152.
26. Asselot-Chapel C, Combacau L, Labat-Robert J, Kern P. Expression of fibronectin and interstitial collagen genes in smooth muscle cells: modulation by low molecular weight heparin fragments and serum. Biochem Pharmacol 1995;49:653-659.
27. Campbell GR, Campbell JH, Manderson JA, Korrigan SH, Rennick E. Arterial smooth muscle: a multifunctionnal mesenchymal cell. Arch Pathol Lab Med 1988;112:977-986.
28. Ang AH, Tachas G, Campbell JH, Bateman JF Campbell GR Collagen synthesis by cultured rabbit aortic smooth muscle cells. Alteration with phenotype. Biochem J 1990;265:461-469.
29. Marchant JK, Hahn RA, Linsenmayer TF, Birk DE. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol 1996;135:1415-1426
30. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol 1996;169:183-265.
31. Ishiwata S, Robinson K, Chronos N, Crocker IR, King SB. Irradiation and postangioplasty restenosis: a recent overview. Jpn Heart J 2000;41:541-570.
32. Hall EJ, Miller RC, Brenner DJ. Radiobiological principles in intravascular irradiation. Cardiovasc Radiat Res 1999;1:42-47.
33. Mayberg MR, Luo Z, London S, Gajdusek C, Rasey J. Radiation inhibition of smooth muscle proliferation after arterial injury. Radiat Res 1995;142:212-220.
34. Ali MN, Kaluza J, Mazur W, Fajardo LF, Schultz D, Bradshaw RA, Berens K, Khan M, Raizner AE. The effect of intracoronary betaradiation on neointimal formation and vascular remodeling in balloon-injured porcine coronary arteries. J Interven Cardiol 1999;12:271-282
35. Sabate M, Serruys PW, van der Giessen WJ, Lighthart JM, Coen VL, Kay IP, Gijzel AL, Wardeh AJ, denBoer A, Levendag PC. Geometric vascular remodeling after balloon angioplasty and beta-radiation therapy: a three-dimensional intravascular ultrasound study. Circulation 1999;100:1182-1188.
36. Burger A, Löffler H, Bamberg M, Rodemann HP. Molecular and cellular basis of radiation fibrosis. Int J Radiat Biol 1998;73:401-408.
37. Followill DS, Travis EL. Differential expression of collagen types I and III in consequential and primary fibrosis in irradiated mouse colon. Radiat Res 1995;144:318-328.
38. Rodman HP, Binder A, Burger A, Guven N, Löffler H, Bamberg M. The underlying cellular mechanism of fibrosis. Kidney Int Suppl 1996;54:S32-S36.
39. Alexakis C, Mestries P, Garcia S, Petit E, Barbier V, Papy-Garcia D, Sagot MA, Barritault D, caruelle JP, Kern P. Structurally different RGTAs modulate collagen-type expression by cultured aortic smooth muscle cells via different pathways involving FGF-2 or TGF-β1. FASEB J. In press.
40. Majors AK, Erhart LA. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp Cell Res 1992;200:168-174.
41. Gajdusek CM, Tian H, London S, Zhou D, Rasey J, Mayberg MR. Gamma radiation effect on vascular smooth muscle cells in culture. Int J Radiat Oncol Biol Phys 1996;36:821-828.
42. MacVittie TJ, Farese AM. Cytokine-based treatment of radiation injury: potential benefits after low-level radiation exposure. Mil Med 2002;167 (Suppl):68-70.
43. Fuks Z, Persaud RS, Alfieri A, McLoughlin M, Ehleiter D, Schwartz JL, Seddon AP, Cordon-Cardon C, Haimovitz-Friedman A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994;54:2582-2590.
44. Chang L, Zhang C, Wu YJ, Zhu RZ. Effects of recombinant human basic fibroblast growth factor on restenosis after arterial endothelial injury in rats. Acta Pharmacol Sin 2001;22:876-880.
45. Tyrrell DJ, Horne AP, Holme KR, Preuss JM, Page CP. Heparin in inflammation: Potential therapautic applications beyond anticoagulation. Adv Pharmacol 1999;46:151-208.
46. Anastase-Ravion S, Carreno MP, Blondin C, Ravion O, Champion J, Chaubet F, Haeffner- Cavaillon N, Letourneur D. Heparin-like polymers modulate proinflammatory cytokine production by liposaccharide-stimulated human monocytes. J Biomed Mater Res 2002;60:375-383.
47. Birk DE, Fitch JM, Barbiaz JB, Doane KJ, Linsenmayer TF. Collagen fibrillogenesis in vitro: interaction of types I and V regulates fibril diameter. J Cell Sci 1990;95:649-657.
48. Meddahi A, Bree F, Papy-Garcia D, Gautron J, Barritault D, Caruelle J.P. Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration. J Biomed Mater Res 2002;62, 525-531.
49. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, Lee CW, Choi D, Jang Y, Lam R, Weissman NJ, Mintz GS. A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med 2003;348:1537-1545.